Search

Magdalena G Eisinger

from Demarest, NJ
Age ~87
Get Report
Also known as:
Magdelana Eisinger, Magdalena G Elsinger, Madgalena Eisinger
Phone and address:
30 Pine Ter, Demarest, NJ 07627
(201) 767-7247
Related to:
Livia Bartels, 26Georgia Bergstrom, 74Bradley C Leth, 40Alison Bergstrom, 48Stefani Leth, 39
Connected to:
Andrew F Eisinger, 38Ashley M Eisinger, 38Carmen S Eisinger, 64Dominic P Eisinger, 60Hal D Eisinger, 70Halley Eisinger, 75Jamie J Eisinger, 37Peter J Eisinger, 32Simon E Eisinger, 56Todd A Eisinger, 68

Magdalena Eisinger Phones & Addresses

  • 30 Pine Ter, Demarest, NJ 07627 (201) 767-7247
  • New York, NY
  • 16 Rock Creek Woods Dr, Lambertville, NJ 08530 (609) 397-8047 (609) 397-9255
  • 30 Pine Ter, Demarest, NJ 07627 (908) 313-8889

Work

Position: Sales Occupations

Education

Degree: Bachelor's degree or higher

Emails

m***[email protected]

Resumes

Resumes

Magdalena Eisinger Photo 1

Distinguished Research Fellow

View page
Location:
New York, NY
Industry:
Cosmetics
Work:
Johnson & Johnson
Distinguished Research Fellow
Magdalena Eisinger Photo 2

Magdalena Eisinger

View page
Location:
30 Pine Ter, Demarest, NJ 07627
Industry:
Writing And Editing
Work:
Johnson & Johnson 1995 - 2009
Distinguished Rresearch Fellow
Skills:
Pharmaceutical Industry
Medical Writing
Drug Discovery
Pharmacology
Medical Devices
Fda
Molecular Biology
Clinical Development
Clinical Research
Oncology
Cell Culture
Biotechnology
Dermatology
Lifesciences
Clinical Trials
Languages:
English

Publications

Us Patents

1,2,4-Thiadiazole Derivatives As Melanocortin Receptor Modulators

View page
US Patent:
7049331, May 23, 2006
Filed:
Nov 4, 2002
Appl. No.:
10/287095
Inventors:
Magdalena Eisinger - Demarest NJ, US
Louis J. Fitzpatrick - Souderton PA, US
Daniel H. Lee - Sudbury MA, US
Kevin Pan - Phoenixville PA, US
Carlos Plata-Salaman - Ambler PA, US
Allen B. Reitz - Lansdale PA, US
Boyu Zhao - Lansdale PA, US
Assignee:
Ortho-McNeil Pharmaceutical, Inc. - Raritan NJ
International Classification:
A61K 31/433
C07D 285/08
US Classification:
514361, 548125, 548128
Abstract:
The present invention is directed to novel 1,2,4-thiadiazole derivatives useful as agonists or antagonists of the melanocortin receptor. More particularly, the compounds of the present invention are useful for the treatment of metabolic, CNS and dermatological disorders such as obesity, impaired oral glucose tolerance, elevated blood glucose levels, type II diabetes, Syndrome X, diabetic retinopathy, spinal cord injury, nerve injury, acute neurodegenerative disorders, chronic neurodegenerative disorders, plexopathies, male erectile dysfunction, dry eyes, acne, dry skin, aged skin, seborrheic dermatitis, rosacea, excessive ear wax, meibomian gland disorder, pseudofolliculitis, yeast infections, dandruff, hidradenitis suppurativa, ocular rosacea and eccrine gland disorder.

1,2,4-Thiadiazolium Derivatives As Melanocortin Receptor Modulators

View page
US Patent:
7319107, Jan 15, 2008
Filed:
Nov 4, 2002
Appl. No.:
10/287096
Inventors:
Magdalena Eisinger - Demarest NJ, US
Louis J. Fitzpatrick - Souderton PA, US
Daniel H. Lee - Sudbury MA, US
Kevin Pan - Phoenixville PA, US
Carlos Plata-Salaman - Ambler PA, US
Allen B. Reitz - Lansdale PA, US
Boyu Zhao - Lansdale PA, US
Assignee:
Johnson & Johnson Consumer Companies, Inc. - Skillman NJ
International Classification:
A61K 31/433
C07D 285/08
US Classification:
514361, 548128
Abstract:
The present invention is directed to novel 1,2,4-thiadiazol-2-ium derivatives useful as agonists or antagonists of the melanocortin receptor. More particularly, the compounds of the present invention are useful for the treatment of metabolic, CNS and dermatological disorders such as obesity, impaired oral glucose tolerance, elevated blood glucose levels, type II diabetes, Syndrome X, diabetic retinopathy, spinal cord injury, nerve injury, acute neurodegenerative disorders, chronic neurodegenerative disorders, plexopathies, male erectile dysfunction, dry eyes, acne, dry skin, aged skin, seborrheic dermatitis, rosacea, excessive ear wax, meibomian gland disorder, pseudofolliculitis, yeast infections, dandruff, hidradenitis suppurativa, ocular rosacea and eccrine gland disorder.

1,2,4-Thiadiazole Derivatives As Melanocortin Receptor Modulators

View page
US Patent:
7375123, May 20, 2008
Filed:
Feb 1, 2006
Appl. No.:
11/344772
Inventors:
Magdalena Eisinger - Demarest NJ, US
Louis J. Fitzpatrick - Souderton PA, US
Daniel H. Lee - Sudbury MA, US
Kevin Pan - Phoenixville PA, US
Carlos Plata-Salaman - Ambler PA, US
Allen B. Reitz - Lansdale PA, US
Boyu Zhao - Lansdale PA, US
Assignee:
Ortho-McNeil Pharmaceutical, Inc. - Raritan NJ
International Classification:
A61K 31/433
C07D 285/08
US Classification:
514361, 548125, 548128
Abstract:
The present invention is directed to novel 1,2,4-thiadiazole derivatives useful as agonists or antagonists of the melanocortin receptor. More particularly, the compounds of the present invention are useful for the treatment of metabolic, CNS and dermatological disorders such as obesity, impaired oral glucose tolerance, elevated blood glucose levels, type II diabetes, Syndrome X, diabetic retinopathy, spinal cord injury, nerve injury, acute neurodegenerative disorders, chronic neurodegenerative disorders, plexopathies, male erectile dysfunction, dry eyes, acne, dry skin, aged skin, seborrheic dermatitis, rosacea, excessive ear wax, meibomian gland disorder, pseudofolliculitis, yeast infections, dandruff, hidradenitis suppurativa, ocular rosacea and eccrine gland disorder.

1,2,4-Thiadiazolium Derivatives As Melanocortin Receptor Modulators

View page
US Patent:
7786311, Aug 31, 2010
Filed:
Aug 5, 2008
Appl. No.:
12/221900
Inventors:
Magdalena Eisinger - Demarest NJ, US
Louis J. Fitzpatrick - Souderton PA, US
Daniel H. Lee - Sudbury MA, US
Kevin Pan - Phoenixville PA, US
Carlos Plata-Salaman - Ambler PA, US
Allen B. Reitz - Lansdale PA, US
Boyu Zhao - Lansdale PA, US
Assignee:
Ortho-McNeil Pharmaceutical, Inc. - Raritan NJ
International Classification:
C07D 285/08
US Classification:
548128, 548125, 564305
Abstract:
The present invention is directed to novel 1,2,4-thiadiazol-2-ium derivatives useful as agonists or antagonists of the melanocortin receptor. More particularly, the compounds of the present invention are useful for the treatment of metabolic, CNS and dermatological disorders such as obesity, impaired oral glucose tolerance, elevated blood glucose levels, type II diabetes, Syndrome X, diabetic retinopathy, spinal cord injury, nerve injury, acute neurodegenerative disorders, chronic neurodegenerative disorders, plexopathies, male erectile dysfunction, dry eyes, acne, dry skin, aged skin, seborrheic dermatitis, rosacea, excessive ear wax, meibomian gland disorder, pseudofolliculitis, yeast infections, dandruff, hidradenitis suppurativa, ocular rosacea and eccrine gland disorder.

Methods For The Treatment Of Dermatological Disorders

View page
US Patent:
8247453, Aug 21, 2012
Filed:
Feb 20, 2009
Appl. No.:
12/389687
Inventors:
Magdalena Eisinger - Demarest NJ, US
Fa Zhang - Belle Mead NJ, US
Assignee:
Janssen Pharmaceutica, NV - Beerse
International Classification:
A61K 31/17
US Classification:
514587
Abstract:
The present invention is directed to the use of a compound of formula (I).

1,2,4-Thiadiazolium Derivatives As Melanocortin Receptor Modulators

View page
US Patent:
8501791, Aug 6, 2013
Filed:
Jul 13, 2010
Appl. No.:
12/835220
Inventors:
Magdalena Eisinger - Demarest NJ, US
Louis J. Fitzpatrick - Souderton PA, US
Daniel H. Lee - Sudbury MA, US
Kevin Pan - Phoenixville PA, US
Carlos Plata-Salaman - Ambler PA, US
Allen B. Reitz - Lansdale PA, US
Boyu Zhao - Lansdale PA, US
Assignee:
Ortho-McNeil Pharamaceutical, Inc. - Raritan NJ
International Classification:
A61K 31/433
C07D 285/08
US Classification:
514361, 548125, 548128
Abstract:
The present invention is directed to novel 1,2,4-thiadiazol-2-ium derivatives useful as agonists or antagonists of the melanocortin receptor. More particularly, the compounds of the present invention are useful for the treatment of metabolic, CNS and dermatological disorders such as obesity, impaired oral glucose tolerance, elevated blood glucose levels, type II diabetes, Syndrome X, diabetic retinopathy, spinal cord injury, nerve injury, acute neurodegenerative disorders, chronic neurodegenerative disorders, plexopathies, male erectile dysfunction, dry eyes, acne, dry skin, aged skin, seborrheic dermatitis, rosacea, excessive ear wax, meibomian gland disorder, pseudofolliculitis, yeast infections, dandruff, hidradenitis suppurativa, ocular rosacea and eccrine gland disorder.

Methods For The Treatment Of Dermatological Disorders

View page
US Patent:
8536226, Sep 17, 2013
Filed:
Jul 11, 2012
Appl. No.:
13/546646
Inventors:
Magdalena Eisinger - Demarest NJ, US
Fa Zhang - Belle Mead NJ, US
Assignee:
Janssen Pharmaceutica, NV - Beerse
International Classification:
A61K 31/17
US Classification:
514587, 514342, 514363, 514361, 514370, 548125, 548128, 564 17
Abstract:
The present invention is directed to the use of a compound of formula (I).

Compositions And Methods For Regulating Phagocytosis And Icam-1 Expression

View page
US Patent:
20020197244, Dec 26, 2002
Filed:
Mar 7, 2002
Appl. No.:
10/092810
Inventors:
Miri Seiberg - Princeton NJ, US
Stanley Shapiro - Livingston NJ, US
Magdalena Eisinger - Demarest NJ, US
International Classification:
A61K038/43
A61K007/00
US Classification:
424/094100, 424/401000
Abstract:
This invention provides compositions of matter for treating and preventing certain mammalian disorders ameliorated by either an increase or decrease in phagocytosis or ICAM-1 expression in appropriate cells. This invention also provides methods of altering the phagocytosis or ICAM-1 expression level in a cell. This invention further provides methods of treating and preventing mammalian disorders affected by the alteration of phagocytosis or ICAM-1 expression. The instant methods and composition of matter all relate to the use of agents that specifically increase or decrease phagocytosis or ICAM-1 expression. Finally, this invention provides related articles of manufacture.
Control profile
Magdalena G Eisinger from Demarest, NJ, age ~87 Get Report